Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

KFSH Scales Genomic Medicine from Research to Clinical Decision-Making

King Faisal Specialist Hospital and Research Centre (KFSH) is pioneering a clinically integrated model of genomic medicine, effectively translating large-scale genetic data into real-time medical decisions that enhance patient care. Over the past two years, KFSH has significantly ramped up its genomic testing capacity, doubling the volume from approximately 22,000 to over 44,000 tests, marking a critical shift towards routine clinical integration. This model not only expands testing but also demonstrates substantial clinical impact, with precision oncology programs facilitating thousands of case analyses and pharmacogenomic insights modifying treatment decisions in up to 70% of documented cases.

The significance of KFSH’s approach lies in its ability to link medical genomics with clinical decision-making, creating a streamlined system that enhances diagnostic accuracy and rectifies previously unresolved or misdiagnosed cases. The integration of genomic data into everyday practice has yielded measurable economic benefits, including reduced reliance on high-cost interventions and shorter intensive care utilization. KFSH’s contributions extend to the global genomic knowledge base, particularly through the identification of genetic variants in underrepresented populations, thereby enriching the diversity and applicability of genomic research.

The implications of this integrated framework are profound for the field of longevity science and healthspan research. By positioning genomics as a foundational component of healthcare delivery rather than a specialized service, KFSH sets a precedent for future healthcare systems. This shift not only facilitates earlier diagnosis and more precise treatment but also fosters data-driven population health strategies, ultimately advancing the goal of enhancing healthspan through personalized medicine. As KFSH presents its model at international forums, it underscores the potential for scalable genomic medicine to transform clinical practice and improve patient outcomes globally.

Source: globenewswire.com